Skip to main content
. 2004 Apr 26;101(18):6993–6998. doi: 10.1073/pnas.0400921101

Fig. 3.

Fig. 3.

Cancer cells with PIKE-A amplification resist to apoptosis. (A) Apoptotic assay. Various human cancers were treated with 250 nM staurosporine for 16 h, and followed by chromatin condensation and fragmentation analysis with DAPI staining. PIKE-A amplified cells display lower apoptotic activity compared to cells with normal copy. (B) Western blotting analysis of Lamin A/C and Caspase-3 cleavage during apoptosis.